Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Eurogentec Ink Probe Manufacturing Pact

NEW YORK (GenomeWeb News) – Belgian reagents manufacturer Eurogentec today said that it has licensed from Life Technologies business Applied Biosystems the rights to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5' nuclease process.

The agreement was signed under AB's Probe Manufacturing License Program and provides Eurogentec with limited pass-through use rights to its research customers. It also provides Eurogentec with rights under several probe composition and method patents to offer oligo design services for probes and primers for use in real-time PCR.

The agreement "confirms the validity of our previous investments in PCR and real-time PCR," Eurogentec CSO Philippe Cronet said in a statement. "In addition to the benefits for the research market, the new agreement is an important cornerstone in our on-going commitment to serve the commercial molecular diagnostic assay market."

Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more